CIK: 0001615982 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 11, 2023
Total Value ($000): $625,361 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,082,622 | $73,336 | 11.7% | $20.23 | +26.8% | COM | 92790C104 |
| COGT | COGENT BIOSCIENCES INC | 4,684,132 | $55,460 | 8.9% | $8.79 | +30.6% | COM | 19240Q201 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,000,000 | $54,210 | 8.7% | $18.41 | 0.0% | COM | 35104E100 |
| ELVN | ENLIVEN THERAPEUTICS INC | 2,230,127 | $45,517 | 7.3% | $20.34 | -0.6% | COM | 29337E102 |
| — | MERUS N V | 1,726,214 | $45,451 | 7.3% | $18.62 | — | COM | N5749R100 |
| GHRS | GH RESEARCH PLC | 3,517,125 | $41,731 | 6.7% | $17.34 | -40.8% | ORDINARY SHARES | G3855L106 |
| — | AMBRX BIOPHARMA INC | 2,484,960 | $40,902 | 6.5% | $8.92 | — | SPONSORED ADS | 02290A102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 2,916,667 | $26,250 | 4.2% | $5.36 | +72.1% | COM | 483497103 |
| TERN | TERNS PHARMACEUTICALS INC | 2,972,869 | $26,013 | 4.2% | $3.72 | +213.7% | COM | 880881107 |
| CABA | CABALETTA BIO INC | 1,973,251 | $25,475 | 4.1% | $3.87 | +180.7% | COM | 12674W109 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $24,457 | 3.9% | $11.80 | 0.0% | COM | 26818M108 |
| CELC | CELCUITY INC | 2,105,386 | $23,117 | 3.7% | $10.24 | +1.5% | COM | 15102K100 |
| SVRA | SAVARA INC | 6,351,531 | $20,293 | 3.2% | $1.32 | +78.3% | COM | 805111101 |
| PHVS | PHARVARIS N V | 1,326,200 | $20,079 | 3.2% | $9.62 | 0.0% | COM | N69605108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1,090,000 | $17,974 | 2.9% | $18.05 | 0.0% | COM | 76243J105 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,142,856 | $16,629 | 2.7% | $5.68 | 0.0% | COM | 68622P109 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,040,754 | $10,793 | 1.7% | $13.57 | -33.3% | COM | 00461U105 |
| TRVI | TREVI THERAPEUTICS INC | 3,422,397 | $8,180 | 1.3% | $2.46 | +2.3% | COM | 89532M101 |
| — | APPLIED THERAPEUTICS INC | 5,658,034 | $7,242 | 1.2% | $1.28 | — | COM | 03828A101 |
| — | THESEUS PHARMACEUTICALS INC | 770,000 | $7,184 | 1.1% | $8.88 | — | COM | 88369M101 |
| MIST | MILESTONE PHARMACEUTICALS IN | 2,208,812 | $6,295 | 1.0% | $7.58 | -50.3% | COM | 59935V107 |
| — | ADVERUM BIOTECHNOLOGIES INC | 3,886,246 | $6,179 | 1.0% | $1.59 | — | COM | 00773U108 |
| — | PRAXIS PRECISION MEDICINES I | 5,304,410 | $6,100 | 1.0% | $1.15 | — | COM | 74006W108 |
| PLRX | PLIANT THERAPEUTICS INC | 288,949 | $5,236 | 0.8% | $21.42 | +10.5% | COM | 729139105 |
| — | LYRA THERAPEUTICS INC | 924,170 | $3,798 | 0.6% | $5.65 | — | COM | 55234L105 |
| — | AEGLEA BIOTHERAPEUTICS INC | 6,343,221 | $2,858 | 0.5% | $0.45 | — | COM | 00773J103 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 353,629 | $1,786 | 0.3% | $2.04 | 0.0% | COM | 09203E105 |
| — | RALLYBIO CORP | 268,532 | $1,520 | 0.2% | $7.55 | — | COM | 75120L100 |
| — | AFFIMED N V | 1,428,571 | $855 | 0.1% | $5.52 | — | COM | N01045108 |
| — | AVALO THERAPEUTICS INC | 1,250,000 | $444 | 0.1% | $1.47 | — | COM NEW | 05338F207 |